Mrs Vilitha Delores Clay, MSW, APSW | |
815 Forward Dr, Madison, WI 53711 | |
(608) 268-6530 | |
(608) 709-1744 |
Full Name | Mrs Vilitha Delores Clay |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 815 Forward Dr, Madison, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174117774 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
1041C0700X | Social Worker - Clinical | 9913-123 (Wisconsin) | Primary |
Entity Name | Anesis Center For Marriage And Family Therapy |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720586761 PECOS PAC ID: 8628491297 Enrollment ID: O20200715001056 |
News Archive
New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor inhibitors first.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
Medicare Advantage Special Needs Plans (SNPs) continue to grow according to Mark Farrah Associates', www.markfarrah.com, latest Business Strategy report.
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Vilitha Delores Clay, MSW, APSW 815 Forward Dr, Madison, WI 53711 Ph: (608) 268-6530 | Mrs Vilitha Delores Clay, MSW, APSW 815 Forward Dr, Madison, WI 53711 Ph: (608) 268-6530 |
News Archive
New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor inhibitors first.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
Medicare Advantage Special Needs Plans (SNPs) continue to grow according to Mark Farrah Associates', www.markfarrah.com, latest Business Strategy report.
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.
› Verified 8 days ago
Ms. Leah Allison Finch, CAPSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Madison, WI 53705 Phone: 608-256-1901 | |
Mr. Thomas A Oconnor, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5534 Medical Circle, Madison, WI 53719 Phone: 608-274-0355 Fax: 608-274-5546 | |
Ms. Fran L Degraff, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2727 Marshall Ct, Madison, WI 53705 Phone: 608-238-9354 Fax: 608-238-7675 | |
Thorsten W. Horton, PHD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 700 Ray O Vac Dr, Suite 220, Madison, WI 53711 Phone: 608-276-9191 Fax: 608-276-9144 | |
Jennifer J Ebbott, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 831 E Washington Ave, Madison, WI 53703 Phone: 608-255-7356 | |
Erin Thomson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1500 Highland Ave, Room 102, Madison, WI 53705 Phone: 608-263-5815 | |
Julia Rhodes, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 700 Rayovac Dr, Ste 103, Madison, WI 53711 Phone: 608-238-5826 |